Vial Closure Supplier Selection: How Pharma Buyers Qualify a Seal Supplier

A pharma buyer qualifies a vial closure supplier by checking six things: the quality system and certifications (ISO 15378, GMP, and a Drug Master File), 100% inspection of the seals, ready-to-use and ready-to-sterilize supply capability, manufacturing capacity and continuity, the documentation and regulatory support package, and the supplier’s dimensional consistency against the vial and stopper. The seal is a primary packaging component that is part of the sterile barrier, so the supplier is qualified as a critical vendor, not bought on price alone. The goal is a partner whose seals crimp reliably at line speed and whose paperwork will stand up in a regulatory filing and an audit.

This guide sets out what a buyer looks for at each stage, from the certifications that gate a shortlist to the documentation that supports a filing.

Key takeaways

A vial seal is primary packaging and part of the sterile barrier, so its supplier is qualified as a critical vendor.
The gating certifications are ISO 15378 (GMP for primary packaging), ISO 9001 and ISO 14001, and a Drug Master File (DMF) the buyer can reference in a filing.
Look for 100% inspection (high-speed camera inspection), a defined AQL, and control over materials and dimensions.
Ready-to-use (RTU) and ready-to-sterilize (RTS) supply, assembled in a classified cleanroom, removes washing and sterilisation steps from the buyer’s line.
Assess capacity, continuity, and documentation (specifications, certificates of analysis, regulatory support) alongside dimensional fit to the vial and stopper.
Sizing and colour flexibility should match the buyer’s portfolio; see how to choose a vial cap size and custom vial seal manufacturing.

Why the seal supplier is a critical vendor

The seal supplier is a critical vendor because the aluminium seal is primary packaging: it crimps over the stopper and holds the sterile barrier in place, so a defect can compromise the product. Unlike a secondary packaging item, a poor or dimensionally inconsistent seal can leave a leak path, jam a capping line, or fail an integrity test after the product is already filled.

That is why the seal is qualified the way a stopper or a vial is, with the supplier assessed for quality systems, process control, and regulatory support. A buyer is not just purchasing a component; they are taking on the supplier’s quality system as part of their own container closure system. The closure’s role in maintaining sterility is covered in sterile vial sealing and vial closure integrity.

Certifications and quality system

The first filter is the supplier’s certifications: ISO 15378 for GMP-grade primary packaging, ISO 9001 for the quality management system, ISO 14001 for environmental management, and a Drug Master File the buyer can reference. These are the credentials that let a seal be used in a regulated injectable and cited in a submission.

ISO 15378: the GMP standard specific to primary packaging materials for medicinal products. It signals that the supplier runs GMP principles, not just a generic quality system.
ISO 9001 and ISO 14001: the quality management and environmental management baselines expected of a serious manufacturer.
Drug Master File (DMF): a confidential dossier lodged with a regulator that a buyer can reference in their own filing, so the seal’s materials and process are documented without the buyer having to re-establish them.
Material compliance: food-contact and pharmacopoeial conformity for the aluminium, lacquer, and plastic, plus BSE/TSE-free and heavy-metal limits.

A supplier that cannot show these is usually screened out before the technical evaluation begins.

Inspection, process control, and material traceability

A qualified supplier inspects every seal, defines an acceptance quality limit, and can trace the materials in each batch. Certifications set the framework; inspection and process control are what deliver a consistent seal batch after batch.

100% inspection. High-speed automated camera inspection of every seal catches dimensional and cosmetic defects that a sampling plan would miss.
Defined AQL. A stated acceptance quality limit (critical, major, minor defect tiers) tells the buyer what quality level the supplier commits to, and lets it be tailored to the application.
Material traceability. The aluminium alloy, the lacquer, and any plastic component should be specified and traceable, with certificates of conformity available per batch.
Dimensional control. Tight, drawing-controlled dimensions are what let the seal crimp cleanly over the matching stopper and vial neck; this is checked against the buyer’s vial and stopper.

Ready-to-use and ready-to-sterilize capability

Ready-to-use (RTU) and ready-to-sterilize (RTS) supply lets the buyer skip washing and sterilising the seals in-house, which shortens their process and reduces bioburden risk. For an aseptic filling line, receiving seals already cleaned, assembled, and sterilised is a meaningful advantage.

Regular: conventional seals the buyer washes and sterilises themselves.
Ready-to-Use (RTU): seals assembled in a classified cleanroom, washed to control particles, double-bagged, and pre-sterilised (typically by gamma irradiation or ETO), ready to enter the aseptic area.
Ready-to-Sterilize (RTS): seals cleaned and packaged so the buyer performs only the final sterilisation step.

The presence of a cleanroom assembly environment and a validated sterilisation route is a strong signal that a supplier can serve sterile injectable production. RTU behaviour through the cold chain is discussed in vial closure for cold-chain drugs.

Capacity, continuity, and documentation

Beyond quality, a buyer checks that the supplier can meet volume reliably and can supply the paperwork a filing and an audit require. A technically excellent seal is only useful if it arrives in the right quantity, on time, with the documents attached.

Capacity and continuity: enough output for the buyer’s volumes, with the process control to keep quality steady as volume scales, and a plan for supply continuity.
Documentation package: product specifications and drawings, certificates of analysis and conformity, the DMF reference, material compliance statements, and stability or shelf-life data.
Regulatory support: willingness to support the buyer’s submissions and audits, and to provide change-control notification if the seal or its process changes.
Sizing and customisation fit: the size range and colour or print options that match the buyer’s portfolio, without inventing a bespoke tool the drawings cannot support.

How this works in practice at Autofits

Autofits is a primary-packaging manufacturer set up to be qualified as a critical seal vendor. Production runs under an ISO 15378:2017 quality system, alongside ISO 9001:2015 and ISO 14001:2015 certification and a Drug Master File, in a 75,000 sq ft Nashik facility. Seals are assembled in an ISO Class 8 cleanroom and undergo 100% high-speed camera inspection, with a defined AQL (critical defects nil; major and minor limits, tailorable). The FlipTop Optima flip-off seals are made from AA8011 aluminium with an epoxy lacquer and a polypropylene button, in 13, 20, 28, 32, and 34 mm sizes (see the by-size hub), and supplied as Regular, Ready-to-Use (gamma or ETO sterilized), or Ready-to-Sterilize. Colours are available in a wide range, matte or glossy, customised to requirement (see by colour and custom vial seal manufacturing). That combination of certification, inspection, RTU/RTS supply, and dimensional control is what a buyer is qualifying when they select a seal supplier.

Frequently asked questions

What certifications should a vial closure supplier have?

A vial closure supplier for injectables should hold ISO 15378, the GMP standard for primary packaging materials, alongside ISO 9001 and ISO 14001. A Drug Master File that the buyer can reference in a regulatory filing is also expected, as it documents the seal’s materials and process. Material compliance statements (food-contact conformity, BSE/TSE-free, heavy-metal limits) round out the credentials.

Why does ready-to-use (RTU) supply matter when choosing a supplier?

Ready-to-use supply matters because it removes washing and sterilisation from the buyer’s line. RTU seals are assembled in a classified cleanroom, washed to control particles, double-bagged, and pre-sterilised, so they can enter the aseptic filling area directly. This shortens the buyer’s process and reduces the bioburden and particle risk they have to manage in-house.

How is a vial seal supplier audited?

A vial seal supplier is audited as a critical primary-packaging vendor. The buyer reviews the quality system and certifications, checks inspection and acceptance quality limits, examines material traceability and process control, confirms cleanroom and sterilisation capability for RTU or RTS supply, and assesses capacity and the documentation package. Dimensional fit to the buyer’s own vial and stopper is verified as part of qualification.

What documentation should a seal supplier provide?

A seal supplier should provide product specifications and drawings, certificates of analysis and conformity per batch, a Drug Master File reference, material compliance statements, and shelf-life or stability data. They should also support the buyer’s submissions and audits and give change-control notification if the seal or its manufacturing process changes.

Is the cheapest vial seal supplier the right choice?

Not usually. A vial seal is primary packaging and part of the sterile barrier, so the supplier is qualified as a critical vendor on quality system, inspection, regulatory support, and dimensional reliability, not on price alone. A seal that jams a capping line or fails an integrity test after filling costs far more than the unit saving, which is why buyers weight qualification over price.

Sources

ISO: ISO 15378:2017, Primary packaging materials for medicinal products, Particular requirements for the application of ISO 9001:2015, with reference to GMP (https://www.iso.org/standard/70845.html)
US FDA: Drug Master Files (DMFs) (https://www.fda.gov/drugs/forms-submission-requirements/drug-master-files-dmfs)
USP-NF: General Chapter <1207>, Package Integrity Evaluation, Sterile Products (https://www.usp.org/)

*Last updated: 2026-07-06. This article is general technical information, not regulatory or compliance advice; confirm current standard editions and your own qualification requirements with the relevant authorities.*